Promoting self-compassion meditation with intranasal oxytocin in borderline personality disorder: a pilot study.
Psychiatry Research June 1, 2026 María Arqueros, J. Soler, David Almenta et al.
BACKGROUND Borderline personality disorder (BPD) is characterized by emotion dysregulation, interpersonal difficulties, and high levels of self-criticism, which may hinder engagement with compassion-based therapeutic practices. Oxytocin has been proposed as a modulator of social-affective processes and may facilitate specific mechanisms involved in psychotherapy. METHODS In this pilot study, 18...